Quipt Home Medical (QIPT) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
6 Jan, 2026Executive summary
Special meeting of shareholders scheduled for March 3, 2026, in Sarasota, FL, to consider a proposed transaction involving 1567208 B.C. LTD and REM Aggregator, LLC.
Record date for notice and voting is January 22, 2026; beneficial ownership determination also set for this date.
Forward-looking statements caution on timing and completion of the transaction, subject to regulatory, court, and shareholder approvals.
Proxy statement and management information circular will be filed and mailed to securityholders; materials will be available on SEC and SEDAR+.
Voting matters and shareholder proposals
Shareholders will vote on the proposed transaction at the special meeting.
Proxy-related materials will be sent directly to non-objecting beneficial owners (NOBO) and delivery to objecting beneficial owners (OBO) will be paid for by the issuer.
Board of directors and corporate governance
Directors and executive officers may be considered participants in the proxy solicitation for the proposed transaction.
Information about directors and officers is available in the annual general meeting proxy statement filed January 24, 2025.
Latest events from Quipt Home Medical
- Revenue up 32% to $80.996M; acquisition at $3.65/share pending; net loss narrows to $1.053M.QIPT
Q1 20269 Feb 2026 - Shareholders to vote on a $3.65/share acquisition with strong board and major holder support.QIPT
Proxy Filing4 Feb 2026 - Shareholders to receive $3.65 per share in cash upon approval of the acquisition arrangement.QIPT
Proxy Filing4 Feb 2026 - Shareholders to vote on $3.65 per share cash buyout, with board and fairness opinions supporting approval.QIPT
Proxy Filing4 Feb 2026 - Revenue rose 10% in Q2 and 6.1% in Q3, with strong margins and recurring revenue over 80%.QIPT
Q3 20241 Feb 2026 - Shareholders to vote on all-cash acquisition after key regulatory milestone achieved.QIPT
Proxy Filing26 Jan 2026 - Shareholders to vote on a $3.65 per share all-cash acquisition with a 39.9% premium.QIPT
Proxy Filing13 Jan 2026 - Record revenue and EBITDA in 2024; organic growth expected to return in 2025.QIPT
Q4 202411 Jan 2026 - Q4 2025 delivered 11% revenue growth and robust recurring revenue, with a positive outlook ahead.QIPT
Q4 202515 Dec 2025